Inventor
DU ZHENJIAN
US33 patents
⚠️ This page may combine multiple inventors who share the name “DU ZHENJIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTA PHARMACEUTICALS CORP
13 patentsUS8053456B2Nov 8, 2011
Triazole compounds that modulate Hsp90 activity
SYNTA PHARMACEUTICALS CORP58 citations98
US8034834B2Oct 11, 2011
Method for treating proliferative disorders with HSP90 inhibitors
SYNTA PHARMACEUTICALS CORP53 citations98
US7825148B2Nov 2, 2010
Triazole compounds that modulate Hsp90 activity
SYNTA PHARMACEUTICALS CORP53 citations98
US8835464B2Sep 16, 2014
Triazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP32 citations93
US7608635B2Oct 27, 2009
Pyrazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP32 citations93
US7662813B2Feb 16, 2010
Triazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP35 citations92
US7763658B2Jul 27, 2010
Treatment for cancers
SYNTA PHARMACEUTICALS CORP21 citations91
US9206162B2Dec 8, 2015
Triazole compounds that modulate Hsp90 activity
SYNTA PHARMACEUTICALS CORP6 citations84
US9006277B2Apr 14, 2015
Triazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP7 citations84
US8921407B2Dec 30, 2014
Pyrazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP7 citations84
US9156794B2Oct 13, 2015
Imidazole compounds that modulate HSP90 activity
SYNTA PHARMACEUTICALS CORP4 citations72
US7884094B2Feb 8, 2011
Compounds for the treatment of proliferative disorders
SYNTA PHARMACEUTICALS CORP2 citations63
US9090603B2Jul 28, 2015
Compounds for the treatment of proliferative disorders
SYNTA PHARMACEUTICALS CORP0 citations52
YING WEIWEN
6 patentsUS8318790B2Nov 27, 2012
Triazole compounds that modulate HSP90 activity
YING WEIWEN49 citations97
US8329899B2Dec 11, 2012
Pyrazole compounds that modulate HSP90 activity
YING WEIWEN21 citations92
US9090569B2Jul 28, 2015
Triazone compounds that modulate HSP90 activity
YING WEIWEN5 citations84
US8901308B2Dec 2, 2014
Triazole compounds that modulate Hsp90 activity
YING WEIWEN7 citations84
US8629285B2Jan 14, 2014
Imidazole compounds that modulate HSP90 activity
YING WEIWEN14 citations84
US8927548B2Jan 6, 2015
Triazole compounds that modulate HSP90 activity
YING WEIWEN10 citations83
DU ZHENJIAN
4 patentsUS8648104B2Feb 11, 2014
Method for treating proliferative disorders associated with mutations in c-Met
DU ZHENJIAN38 citations93
US8969396B2Mar 3, 2015
Method for treating a B-raf associated cancer with an Hsp90 inhibitor
DU ZHENJIAN7 citations82
US8993608B2Mar 31, 2015
Method for inhibiting topoisomerase II
DU ZHENJIAN7 citations72
US9108933B2Aug 18, 2015
Method for treating proliferative disorders associated with mutations in c-Met
DU ZHENJIAN3 citations60